Epigenomic diagnostics have shown DNA methylation of various prognostic transcription factors and immune checkpoints (PITX2, SHOX2, SEPT9, PD-1, and CTLA4) to be correlated with HNSCC and potentially associated with targeted therapies [84]. The gene discussed is CTLA4; the disease is head and neck squamous cell carcinoma.